6550--Sources Sought: Cepheid GeneXpert Infinity Reagents
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36C24826Q0193
- Agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Department of Veterans Affairs Bay Pines VA Healthcare System and Bay Pines FL 33744, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VISN 8) seeks to procure Cepheid GeneXpert Infinity Reagents for infectious disease testing through a sole source, fixed-price Indefinite Delivery Indefinite Quantity (IDIQ) contract. The procurement covers an extensive range of molecular diagnostic tests including MRSA, Clostridioides difficile toxin, carbapenem-resistant enterobacteria, chlamydia/gonorrhea, Group A Streptococcus, SARS-CoV-2, influenza, respiratory syncytial virus, and vaginal infection molecular tests designed for use on the Cepheid GeneXpert Infinity system already owned by the facility. The government believes Cepheid is the only authorized provider capable of meeting these specialized requirements due to the unique nature of the reagents and their compatibility with existing equipment. The evaluation will focus on demonstrating the ability to comply with the requirement and provide these specific diagnostic reagents. Interested parties may submit responses by January 9, 2026, at 1:00 PM Eastern Time to potentially influence whether the government pursues a competitive procurement instead of the proposed sole source award.
This procurement is not designated as a set-aside and involves contracting with the identified incumbent, Cepheid, as the sole source provider. No specific award value or budget range has been disclosed in the sources sought notice. The notice does not specify quantity requirements for the reagents or a defined service timeline, indicating the IDIQ structure will allow for variable ordering based on operational needs. Responses to this sources sought notice will be considered solely at the government's discretion to determine whether to proceed with competitive procurement or move forward with the sole source acquisition from Cepheid. If no alternative responses are received by the deadline, the VA will proceed directly to award the sole source contract to Cepheid.
Notice text
This Notice of Intent is provided to advise that the Government intends to solicit and negotiate a Sole Source, Fixed-Priced Single Award Indefinite Delivery Indefinite Quantity (IDIQ) with only one source, Cepheid. This procurement is for an extensive range of infectious disease testing covering microorganisms such as Methicillin Resistant Staph aureus (MRSA), Clostridioides (Clostridium) difficile Toxin (C diff), Carbapenemase Resistant Enterobacteriaceae (CRE), Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG), Beta hemolytic Streptococcus Group A (Streptococcus pyogenes), SARS-Coronavirus-2, Hemophilus influenzae (influenza A and influenza B), Respiratory syncytial virus (RSV), and Vaginal Infection Molecular Test to be used on the Cepheid GeneXpert Infinity that is owned by the facility.
This action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 12.102 (b) and 41 USC §1901, only one will meet the Government s needs. Only one source is capable of responding due to the unique or specialized nature of the supplies and/or services. It is the Government s belief that the proposed candidate is the only authorized provider of the reagents that can meet the agency s needs. Interested persons may identify their interest and capability to respond to the requirement.
This notice of intent is not a request for competitive proposals and no solicitation is available. Any responses received will only be considered for the purposes of determining whether to conduct a competitive procurement in lieu of sole source contract described in this notice, and such determination shall be made at the sole discretion of the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the requirement. If no responses are received, the government will proceed with the Sole Source acquisition. Any response should be emailed to Moneque Rodriguez at moneque.rodriguez@va.gov by 13:00PM Eastern Standard Time on January 09, 2026.
Files
| File | Type | Posted |
|---|---|---|
| 36C24826Q0193.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--Cepheid GeneXpert Infinity Molecular Reagents IDIQ | Award Notice | |
| 6550--Intent to Sole Source: Cepheid GeneXpert Infinity Molecular Reagents IDIQ | Solicitation | |
| 6550--Intent to Sole Source: Cepheid GeneXpert Infinity Molecular Reagents IDIQ | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity